HOME Press Releases Genomics Market worth 23.88 Billion USD by 2022



Genomics Market worth 23.88 Billion USD by 2022


The report "Genomics Market by Product and Services (Instruments/Systems, Consumables, Services), Technology (Sequencing, Microarray, PCR), Process (Library Preparation, Sequencing, Data Analysis), Application (Diagnostics) - Forecast to 2022", The Genomics market is expected to reach USD 23.88 Billion by 2022 from an estimated USD 14.71 Billion in 2017, at a CAGR of 10.2%. The key factors such as growth in the number of R&D activities, growing demand for personalized medicine and reducing cost of sequencing services are driving the growth of this market.

                             Download PDF Brochure     Speak to Analyst     Inquiry Before Buying

Browse 112 Market Data Tables and 43 Figures spread through 218 Pages and in-depth TOC on "Genomics Market by Product and Services (Instruments/Systems, Consumables, Services), Technology (Sequencing, Microarray, PCR), Process (Library Preparation, Sequencing, Data Analysis), Application (Diagnostics) - Forecast to 2022"
https://www.marketsandmarkets.com/Market-Reports/genomics-market-613.html
Early buyers will receive 10% customization on reports.

By products and services, the consumables segment accounted for the largest share of the market in 2017

On the basis of products and services, the genomics market has been segmented into instruments/systems, consumables and services. In 2017, the consumables segment is expected to account for the largest share of the global Genomics market. The services segment, on the other hand, is expected to be the fastest-growing segment during the forecast period. Growth in this segment is mainly driven by the increase in the biotechnology and genomics services start-ups, adoption of genetic testing by hospitals and decrease in the sequencing costs.

By technology, the PCR technology accounted for the largest share of the market in 2017

On the basis of technology, the genomics market has been segmented into sequencing, microarray, PCR, nucleic acid extraction and purification and other technologies such as genotyping and gene editing. In 2017, the PCR technology is expected to account for the largest share of the global Genomics market. The sequencing technology, on the other hand, is expected to be the fastest-growing segment during the forecast period. Growth in this technology attributes to the increase in genomics application areas, and advancements in the sequencing technology such as high throughput sequencing.

By process, the sequencing segment accounted for the largest share of the market in 2017

On the basis of process, the genomics market has been segmented into library preparation, sequencing and data analysis. In 2017, the sequencing is expected to account for the largest share of the global Genomics market. It is also expected to be the fastest-growing segment during the forecast period. Growing adoption of genetic testing by hospitals and decreasing costs of sequencing services are expected to drive the growth of the segment.

North America dominated the market in 2017

North America accounted for the largest share of the Genomics market in 2017, followed by Europe. The large share of the North American Genomics market can be attributed to the growth in biotechnology and genomics research grants and funds in the US, focus on precision medicine and pan-Canadian program.

The various players in the Genomics market include F. Hoffmann-La Roche (Switzerland), Thermo Fisher Scientific (US), BGI (China), Illumina (US), QIAGEN (Netherlands), GE Healthcare (UK), Bio-Rad Laboratories (US), Eurofins Scientific (Germany), Agilent Technologies, (US), Oxford Nanopore Technologies (UK), Pacific Biosciences of California (US), and Eppendorf (Germany) among others.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street,
Suite 2175, Seattle,
WA 98101, United States
1-888-600-6441
Email: sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports